Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity.
about
Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokinesDelivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection.Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells.Fighting infection using immunomodulatory agents.Animal pneumoviruses: molecular genetics and pathogenesis.Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathologyNonsegmented negative-strand viruses as vaccine vectors.Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice.Natural products and synthetic compounds as immunomodulators.Carriers for the delivery of a vaccine against respiratory syncytial virus.Virally delivered cytokines alter the immune response to future lung infectionsPrevention and treatment of respiratory syncytial virus infection in infants: an update.Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection.Respiratory syncytial virus infection: from biology to therapy: a perspective.A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.Respiratory syncytial virus--a comprehensive review.2'-5' Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells.Modulation of the host immune response by respiratory syncytial virus proteins.Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine.
P2860
Q33769399-D8D18D94-38C9-4B28-A092-2CD2B3BDC968Q33809197-1A251B05-42D7-4D98-94BF-4C106B71CA03Q33826900-23D4E522-E8E5-4D34-B28B-43E15AAC61EFQ33870105-AA4862C1-B0AD-495B-9B0A-D2D2F2BC2D7EQ34103603-9E486582-2E50-40DC-9434-ECE9B8FE3B4FQ34313560-D410243C-83C3-49F6-AF9E-ABCCFD6405D8Q34364942-FE43B576-6D6E-434A-969B-CEAED75FE706Q35139219-1823BB6B-B59B-48A9-A2A2-8CA80833664CQ35897408-8A0AE34B-97C8-44EB-A287-8D9C2251E9E8Q35917221-59242CB1-4398-4B7C-8E13-9A497FA9DC86Q36194078-3436169B-1099-4E5E-A0F9-9866C67A71F3Q36315800-86ABD3E7-56CA-4D29-AEE5-8D8C0DB5F3F7Q36445553-8ADE82D2-1F15-423E-A921-85F4B0C61D6DQ36747814-8E7B9D77-F4BC-4B2E-B96F-A29EAD25C2AFQ36834294-0A3A08B3-BF3F-4849-8967-F9068C17BAB3Q37492711-1C5017C7-465F-45B7-8386-9887BB3E6166Q38098094-43028C40-049F-4022-B466-88203A442BBEQ38289747-18B01C16-87E4-4BED-B2B4-A8B15528160BQ39154023-A4B09773-8DDE-4C3C-9DA8-6C69611A5526Q49296005-AEFBEF25-5906-4EB4-9974-586AEF892049
P2860
Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interferon gamma expressed by ...... t compromising immunogenicity.
@en
Interferon gamma expressed by ...... t compromising immunogenicity.
@nl
type
label
Interferon gamma expressed by ...... t compromising immunogenicity.
@en
Interferon gamma expressed by ...... t compromising immunogenicity.
@nl
prefLabel
Interferon gamma expressed by ...... t compromising immunogenicity.
@en
Interferon gamma expressed by ...... t compromising immunogenicity.
@nl
P2093
P2860
P356
P1476
Interferon gamma expressed by ...... t compromising immunogenicity.
@en
P2093
Bukreyev A
Bukreyeva N
Collins PL
Whitehead SS
P2860
P304
P356
10.1073/PNAS.96.5.2367
P407
P577
1999-03-01T00:00:00Z